Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/56261
Title: COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.
Authors: 
Mesh: 
Issue Date: 15-Mar-2021
Citation: Cancer.2021;(127)11:1937-1938
PMID: 33721325
URI: https://hdl.handle.net/20.500.12530/56261
Rights: openAccess
Appears in Collections:Centros de Atención Primaria > Artículos

Files in This Item:
File SizeFormat 
PMC8250378.pdf72.7 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.